<DOC>
	<DOCNO>NCT02643823</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy human umbilical cord mesenchymal stem cell ( hUC-MSC ) Rheumatoid Arthritis .</brief_summary>
	<brief_title>Human Umbilical Cord-Mesenchymal Stem Cells Rheumatoid Arthritis</brief_title>
	<detailed_description>Human umbilical cord mesenchymal stem cell exhibit potential differentiate chondrocyte osteocyte , confirm vivo vitro experiment . There clinical report describe umbilical cord mesenchymal stem cell treatment Rheumatoid Arthritis . To investigate effect hUC-MSC treatment Rheumatoid Arthritis , 20 patient Rheumatoid Arthritis enrol receive 4 time hUC-MSC transplantation .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Aged 1880 Rheumatoid Arthritis patient ; Patients must consent write participate study sign date informed consent document ; Patients must diagnosis Rheumatoid Arthritis accord 2010 ACR/EULAR criterion least 12 week duration ; Stage I II accord Xray . History neurological disease , head injury psychiatric disorder ; Pregnant woman ; Impaired liver function , abnormal blood coagulation , AIDS , HIV , combine tumor special condition ; Progressive apoplexy ; With malignant tumor ; Patients participate clinical trial within three month prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Human Umbilical Cord Mesenchymal Stem Cell</keyword>
	<keyword>Mesenchymal Stem Cell</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>